Background: The systematic analysis of morbidity and mortality for the Food and Drug Administration (FDA)-approved medical abortion regimen using mifepristone is possible using data from the FDA's ...
[52] Based on the data from this trial, the FDA approved mifepristone for use as an abortifacient up to 49 days from the LMP, but failed to require sonographic data for the accurate determination ...
d) any conceptus that is present and fails to implant will have been destroyed as an unintended and even unforeseen effect given the “lack of evidence supporting abortifacient effects of the ...
In 2021, the Food and Drug Administration removed requirements for patients to see a physician in person prior to being prescribed mifepristone, allowing the abortifacient to be sold online and by ...